Simulation Study of Alpha Range in Boron Neutron Capture Therapy

Abstract

Boron neutron capture therapy trials, BNCT trials, took place in the United States firstly, BNCT was still far from mainstream medicine at that time [1]. However, in recent years, BNCT has already been applied in the therapy of many major diseases, including cancer, and recurrent glioma for example. BNCT is an extremely effective cancer treatment, which has a unique property of tumor-cell-selective heavy-particle irradiation. BNCT can form large dose gradients between cancer cells and normal cells, even if the two types of cells are mingled at the tumor margin [2]. Through BNCT, the difficulty of treating these major diseases has been solved piecemeal. Therefore, patients can see glimmers of hope and the future of BNCT has been given some optimism. This article mainly introduces the advantages of BNCT over others and the Physical Mechanism of BNCT. It supports my view of applying BNCT according to the simulated experimental data.